Hi Greg,
Very interesting report about treatment! Since my dx 2006 i have been looking for info about what patients that will respond to a special treatment. The info about the TET2 mutation - one study showed that 83% of patients with this mutation responded to Vidaza - is one of many reports about how to choose the best treatment for a patient.
Otherwise the rather old small study about Vidaza in combination with Zolinza (a HDAC inhibitor) has given the best results I have seen - 86%:
http://ash.confex.com/ash/2008/webpr...aper15277.html
Hope your doctor and you will find a good treatment for you!
Kind regards
Birgitta-A